hero-line-left hero-line-top

Bringing precision medicine to more patients

Our life sciences partners are helping us answer tough questions about complex issues in cancer care



Roche and Syapse are collaborating on methods for measuring real-world outcomes, and are exploring additional areas of collaboration with the potential to bring precision medicine and improve care for more patients.


Amgen and Syapse are creating opportunities for physicians and researchers within the Syapse Network to gain access to analytics, real-world evidence-based insights, and collaborative research opportunities. Amgen will also work with Syapse to develop real-world evidence standards to support the acceleration of therapies to market.

In the news

South Korea’s SNUH extends partnership with Syapse to expand access to precision medicine

8/9/19 - Syapse, a company accelerating precision medicine through insights derived from its global health system network, and Seoul National University Hospital (SNUH) in South Korea announced that they have extended their partnership with a new multi-year agreement. As part of their partnership, SNUH and Syapse will collaboratively work towards building South Korea’s first real-world data sharing network for leading precision oncology hospitals in the region.



Precision Medicine Goes Mainstream at Leading Health Systems

Precision medicine (or personalized medicine) has been a buzzword in the healthcare industry for many years. Depending on the audience, its…